% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

  • bioimmunomabman bioimmunomabman Jul 12, 2013 2:25 PM Flag

    No sellers

    I was thinking short squeeze when I saw the price, but volume is waaay too low, so the squeeze has not even started, but it may soon. Someone may be getting a call soon, ring ring, ah my shorty, we can no longer lend the shares, you will have to cover NOW.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Shorts will get killed here....................sooner than later!

      Sentiment: Strong Buy

    • Alexion is up a bit over $3 billion in market cap on the Roche rumor. This brings them north of a $20 billion market cap. Their lead drug brought in $1.3 billion in sales last year. I don't see Roche paying that much for a billion dollar drug. Their pipeline has some conjugated antibodies in it, but then why not just by IMGN who is one of the recognized leaders in that space. Might have to look at some ALXN puts because that take over does not make much sense to me.

      Chinese Hamsters

      • 1 Reply to chinesehamsters
      • Did you get those ALXN puts? They look fairly expensive, if you bought some in the money puts the other day, you might want to sell some lower priced puts today. I was a little early with the DIA and SPY puts. I bought them to hedge in an overbought market, but I still hate to see them decline even knowing I bought them for hedging risk.

        I noticed an artice on CRIS this morning that makes an interesting case based on the early stage products. I am not a fan of CRIS management, but maybe they have some good new people that will move the company forward and stop making stupid financial decisions. I am ONLY going to buy this dog again on weakness, I will not pay high $3's.

    • Bio, I think the move on low volume relates to the fact that we're in a confirmed breakout above all resistance. I would not want to be a short going into this weekend.

3.14+0.03(+0.96%)Aug 23 4:00 PMEDT